Community consensus on the earlier inclusion of pregnant women and persons in TB research
A consensus statement provides a framework for ensuring that pregnant and breastfeeding women and persons are better served by TB research and can fully benefit from scientific advancements in the prevention and treatment of TB.
In October 2023, sixteen members of the global TB community developed a consensus statement on the inclusion of pregnant and breastfeeding women and persons in TB treatment and vaccines research. The community meeting where this consensus was developed was part of a broader convening hosted by the Supporting, Mobilizing, and Accelerating Research for Tuberculosis Elimination (SMART4TB) Consortium, the International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Network, and the World Health Organization (WHO) Global TB Program in Washington, D.C.
The community consensus statement draws from the participants direct experiences with TB, including during pregnancy, and conversations with TB scientists and clinicians. The consensus statement provides a framework for ensuring that pregnant and breastfeeding women and persons are better served by TB research and can fully benefit from scientific advancements in the prevention and treatment of TB.
Access the community consensus statement here.
Source: Treatment Action Group
